Clinical Response of Advanced Lung Adenocarcinoma with Class III BRAF G466V Missense Mutation to Dabrafenib and Trametinib: A Case Report

Fang R, Xu S, Gong J, Liao Z

OncoTargets and Therapy 2024, 17:27-31

Published Date: 23 January 2024